Sana Biotech To Establish Manufacturing Facility For Gene, Cell Therapy Candidates

by Vandana Singh, Benzinga Editor
July 15, 2021 7:29 AM | 1 min read |
  • Sana Biotechnology Inc SANA has entered into a lease agreement to develop a 163,000 square foot manufacturing facility in Fremont, California. 
  • The facility will support the manufacture of Sana's late-stage clinical development and early commercial product candidates.
  • The facility will be designed to provide manufacturing capabilities across Sana's portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production. 
  • The Company also plans to work with contract manufacturing partners to advance its product candidates to the clinic as early as next year.  
  • Price Action: SANA shares closed at $17.42 on Wednesday.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: BiotechNewsHealth CareGeneralBriefsgene therapy
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved